Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Michele L. Cote
Research Interests
Explore related searches
Articles (4)
Year:
2025
Year:
2025
Year:
2025
Background The use of electronic cigarettes (e‐cigarettes) is increasing rapidly in the United States, although the negative health outcomes associated with these products are still unknown. Emerging research has examined the use of e‐cigarettes in the cancer survivor population as a whole, yet none has focused on e‐cigarette use in the African American (AA) cancer survivor population. Methods The authors used data from the Detroit Research on Cancer Survivors cohort study, comprised of AA adult cancer survivors. Logistic regression models were used to evaluate factors potentially associated with e‐cigarette ever use and current use. Results Of 4443 cancer survivors who completed a baseline interview, 8.3% ( n = 370) reported ever using e‐cigarettes, and 16.5% ( n = 61) of those reporting ever use also reported current use of e‐cigarettes. Ever users and current users were on average younger than those who did not use e‐cigarettes (57.5 vs. 61.2 years; p < .001). Current cigarette smokers were >20 times more likely (odds ratio, 20.75; 95% confidence interval, 12.84–33.55) and former smokers were almost 10 times more likely (odds ratio, 9.50; 95% confidence interval, 6.03–14.97) to have ever used e‐cigarettes than never‐smokers. Preliminary data suggested that ever use of e‐cigarettes is associated with later stage at diagnosis for breast and colorectal cancers. Conclusions As the use of e‐cigarettes increases in the general population, it is important to continue to monitor their use in cancer survivors and to gain more insight as it pertains to the AA cancer survivor population. Elucidation of the factors associated with e‐cigarette use in this population may help inform comprehensive cancer survivorship recommendations and interventions.
Year:
2023
Collaborators (5)
Ariel Washington
Assistant Professor
Wayne State University
Lindsay J Collin
Assistant Professor
Emory University
Anke Hüls
Assistant Professor
Emory University School of Public Health
Melissa Bondy
Professor/Department Chair
Stanford University
Elisa Bandera
Chief
Rutgers Cancer Institute of New Jersey
Make your next move.
Prepare your application
Review drafts before you send them.